Abstract
Objective
The main objective of the randomized controlled trial (RCT) was to evaluate the short-term osteogenic effects of mandibular cortex bone (MCB) versus iliac cancellous bone (ICB) after secondary alveolar bone graft.
Design
RCT.
Setting
Department of Oral and Cranio-Maxillofacial Surgery in the Shanghai Ninth People's Hospital from September 1, 2020, to August 31, 2023.
Patients
Patients with unilateral alveolar cleft.
Interventions
Those who met the inclusion criteria were randomly assigned to receive either MCB or ICB grafting. Clinical and radiographic examinations were performed preoperatively and immediately, as well as at 1, 3, 6, 12, 18, and 24 months postoperatively.
Main Outcome Measure(s)
The bone resorption rate was measured 6 months postoperatively. Clinical observations included adverse events and hospitalization details including length of surgery, intraoperative bleeding, length of stay, and costs.
Results
A total of 28 patients were included, with 16 allocated to the MCB group and 12 to the ICB group. The bone resorption rate in the MCB group (45.20 ± 29.81%) was significantly lower than that in the ICB group (74.87 ± 18.48%) (P = 0.005). Two adverse events were reported in the MCB group. The MCB group had significantly greater costs (P < 0.001), a significantly shorter length of stay (P < 0.001), and a significantly longer duration of surgery (P = 0.026). However, there were no significant differences in terms of intraoperative bleeding.
Conclusion
Compared with ICB, MCB demonstrated a slower bone resorption rate in the short term for treating secondary alveolar cleft in this study, albeit with increased surgical time and costs.
Trial Registration
Registry number: ChiCTR2000034227 [URL: https://www.chictr.org.cn/showprojEN.html?proj=55737].
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
